DSIP（10 VIALS / BOX）

Synthetic Peptide for Sleep Architecture Research

Technical Overview

DSIP 5mg is a synthetic peptide compound developed for laboratory research involving delta-wave EEG activity and hypothalamic-pituitary signaling, receptor interaction analysis, and controlled experimental investigation. In research settings, this peptide is commonly utilized for studying NMDA-receptor-associated neuromodulation, hypothalamic-pituitary-adrenal axis dynamics, and related biochemical mechanisms.

Delta Sleep-Inducing Peptide (DSIP) is a nonapeptide originally isolated from cerebral venous blood of sleeping rabbits. Its sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu has been shown to modulate delta-wave EEG activity and to interact with NMDA-receptor pathways, though its endogenous precursor remains uncharacterized.

Researchers use DSIP in rodent EEG studies, neuroendocrine-stress models, and comparative neuropeptide pharmacology. It is also investigated as a tool for probing the relationship between sleep architecture, circadian neuroendocrine output, and stress-response signaling.

This compound is synthesized using established solid-phase peptide synthesis methods and purified through reversed-phase HPLC to achieve analytical purity suitable for laboratory assays, binding studies, and analytical applications. The lyophilized material is supplied for reconstitution per established laboratory protocols and is intended as a reference material in controlled research environments.

Specifications

Compound Name: DSIP
Strength: 5mg
Purity: ≥ 99% (HPLC Verified)
Appearance: Lyophilized Peptide Powder
Format: Research Compound
Reconstitution: Suitable for laboratory assay preparation.

Notice

Provided as a reference material for scientific investigation only.